Cognitive Dysfunction in Postural Tachycardia Syndrome

August 15, 2016 updated by: Satish R. Raj, Vanderbilt University

Origins of Cognitive Dysfunction in Postural Tachycardia Syndrome (POTS)

A common complaint among people with Postural Tachycardia Syndrome (POTS) is "brain fog" or difficulty concentrating. This is very poorly understood. To better understand this cognitive dysfunction, the investigators will test people with POTS and people without POTS using various neuropsychiatric instruments. The investigators hypothesis is that people with POTS will have greater abnormalities on neuropsychiatric testing than normal controls.

Study Overview

Detailed Description

Postural Tachycardia Syndrome (POTS) is a disorder that affects an estimated 500,000 people in the United States alone and is an important source of disability in young adults. It shows a strong predilection for females. POTS is a form of orthostatic intolerance characterized by an excessive increase in heart rate (>30 bpm) on assuming the upright position associated with orthostatic symptoms, but in the absence of orthostatic hypotension. Their symptoms of dizziness, nausea, tremor, chronic fatigue and exercise intolerance make even simple activities of daily living exhausting prospects.

Brain fog or cognitive dysfunction is a common and almost universal complaint among persons with POTS. There is a lack of pathophysiological understanding to this cognitive dysfunction and is also a major roadblock to the development of effective therapies for people with POTS.

The purpose of this study is to better define the cognitive dysfunction seen in patients with POTS. We will use a series of validated neuropsychological tools in order to characterize POTS cognitive dysfunction and compare this data to age and gender matched control subjects.

Specific Aims:

  1. To assess whether POTS patients have more neuropsychological abnormalities than control subjects during seated assessments.
  2. To assess whether POTS patients have more neuropsychological abnormalities than control subjects during assessments while standing.
  3. To ascertain the phenomenology of any neuropsychological deficits distinguishing POTS patients from controls.

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37232
        • Vanderbilt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients having been diagnosed with postural tachycardia syndrome and age & gender matched normal controls

Description

Inclusion Criteria:

All

  • Ages between 18-60 years
  • Male and female subjects are eligible
  • Able and willing to provide informed consent

POTS - additional inclusion criteria - Diagnosed with postural tachycardia syndrome by Vanderbilt Autonomic Dysfunction Center (increase in heart rate greater than or equal to 30 beats per minute with position change from supine to standing (10 minutes; chronic symptoms consistent with POTS that are worse when upright and get better with recumbence.)

Control subjects - additional inclusion criteria

  • Gender matched to POTS patients
  • Age-matched to POTS patients (+/- 5 years of a POTS patient)
  • Grossly matched in intelligence to POTS patients

Exclusion Criteria:

ALL

  • Inability to give or withdrawal of informed consent
  • Pregnancy (determined by patient self report)
  • Other factors which in the investigator's opinion would prevent the subject from completing the protocol.

POTS - additional exclusion criteria

- Overt cause for postural tachycardia (such as acute dehydration)

Normal Controls - additional exclusion criteria

  • Previously diagnosed with Axis I psychiatric disorder
  • Previously diagnosed learning disorder
  • Previously diagnosed attention deficit hyperactivity disorder (ADHD)
  • Prior psychosis
  • past or present substance abuse
  • History of loss of consciousness
  • History of seizures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Normal Controls / Healthy Volunteers
Age and gender matched individuals without postural orthostatic tachycardia syndrome

The following measurements will take place in a seated position:

Ruff 1 & 7 (visual search and attention processes) Trails A & B (Tests of scanning, mental flexibility and executive processes) Symbol Digit Modalities Test (SDMT)(attention and psychomotor speed) Stroop Test (naming response to certain stimuli) Verbal Fluency (COWA) Randt Wechsler Test of Adult Reading (WTAR)

The following will be measured in a standing position (at least 5 minutes)

Orthostatic Vital Signs Randt Paired Words Subtest Digits Forward and Backward Alternate COWA test

Center for Epidemiologic Studies Depression Scale (CES-D) Cognitive-Somatic Anxiety Questionnaire (CSAQ) Subjective Neurocognitive Inventory (SNI)
Patients with Postural Tachycardia Syndrome (POTS)
Individuals with Postural Tachycardia Syndrome

The following measurements will take place in a seated position:

Ruff 1 & 7 (visual search and attention processes) Trails A & B (Tests of scanning, mental flexibility and executive processes) Symbol Digit Modalities Test (SDMT)(attention and psychomotor speed) Stroop Test (naming response to certain stimuli) Verbal Fluency (COWA) Randt Wechsler Test of Adult Reading (WTAR)

The following will be measured in a standing position (at least 5 minutes)

Orthostatic Vital Signs Randt Paired Words Subtest Digits Forward and Backward Alternate COWA test

Center for Epidemiologic Studies Depression Scale (CES-D) Cognitive-Somatic Anxiety Questionnaire (CSAQ) Subjective Neurocognitive Inventory (SNI)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Standing Digits Backwards Test
Time Frame: In the standing position for approximately 15 minutes. This is a cross-sectional study with no follow-up.
This is a continuous variable that will provide a measure of attention with orthostatic stress.
In the standing position for approximately 15 minutes. This is a cross-sectional study with no follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cognitive Domain Score (CDS)
Time Frame: At seated and standing. This is a cross-sectional study without follow-up. All assessments are performed on a single day.

The CDS will consist of

1: Seated memory (Randt Short Story subtes, Paired words subtes and Digits Forward) and standing memory (Randt short story, paired words and digits forward).

2. Seated Complex Attention (Ruff, SDMT, Trails A, Randt, Digits Backward) and standing complex attention (Randt digits backward) 3. Executive functioning only while standing (Stroop, Trails) 4. Seated and standing verbal fluency (COWA).

At seated and standing. This is a cross-sectional study without follow-up. All assessments are performed on a single day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Satish Raj, MD, MSCI, Vanderbilt University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

February 17, 2011

First Submitted That Met QC Criteria

June 2, 2011

First Posted (Estimate)

June 6, 2011

Study Record Updates

Last Update Posted (Estimate)

August 17, 2016

Last Update Submitted That Met QC Criteria

August 15, 2016

Last Verified

August 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postural Tachycardia Syndrome

Clinical Trials on Seated Measurements

3
Subscribe